Coolstocks, first of all calm down mate, its not the end of the world.
Second, Independent Data Safety Monitoring Board review after first patient in each cohort and between cohorts takes time.
Thirdly you will also note that they are looking at commencing recruitment of additional clinical trials sites, in addition to Duke and recently commissioned second site UCSD to speed it all up.
Also am i wrong in saying that after the next results come out it will validate safety?
Is that not a good thing?
Would that not push the SP up?
- Forums
- ASX - By Stock
- BLT
- Ann: HCV TRIAL UPDATE
Ann: HCV TRIAL UPDATE, page-16
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BLT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online